(Q35070184)

English

Diltiazem treatment for pre-clinical hypertrophic cardiomyopathy sarcomere mutation carriers: a pilot randomized trial to modify disease expression

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

6 August 2017

Diltiazem treatment for pre-clinical hypertrophic cardiomyopathy sarcomere mutation carriers: a pilot randomized trial to modify disease expression (English)

1 reference

Europe PubMed Central

6 August 2017

hypertrophic cardiomyopathy

1 reference

based on heuristic

inferred from title

object named as

Begoña López

11

0 references

Elliott M Antman

8

object named as

Elliott M Antman

1 reference

Europe PubMed Central

6 August 2017

Steven E Lipshultz

4

object named as

Steven E Lipshultz

1 reference

Europe PubMed Central

6 August 2017

Christopher Semsarian

9

object named as

Christopher Semsarian

1 reference

Europe PubMed Central

6 August 2017

Endel John Orav

13

object named as

E John Orav

1 reference

Europe PubMed Central

6 August 2017

14

object named as

Steven D Colan

1 reference

Europe PubMed Central

6 August 2017

Christine E. Seidman

15

object named as

Christine E Seidman

1 reference

Europe PubMed Central

6 August 2017

Allison L Cirino

3

object named as

Allison L Cirino

1 reference

Europe PubMed Central

6 August 2017

author name string

Carolyn Y Ho

1

1 reference

Europe PubMed Central

6 August 2017

Neal K Lakdawala

2

1 reference

Europe PubMed Central

6 August 2017

Elizabeth Sparks

5

1 reference

Europe PubMed Central

6 August 2017

Siddique A Abbasi

6

1 reference

Europe PubMed Central

6 August 2017

Raymond Y Kwong

7

1 reference

Europe PubMed Central

6 August 2017

Arantxa González

10

1 reference

Europe PubMed Central

6 August 2017

Javier Diez

12

1 reference

Europe PubMed Central

6 August 2017

publication date

31 October 2014

1 reference

Europe PubMed Central

6 August 2017

JACC: Heart Failure

1 reference

Europe PubMed Central

6 August 2017

3

1 reference

Europe PubMed Central

6 August 2017

2

1 reference

Europe PubMed Central

6 August 2017

180-188

1 reference

Europe PubMed Central

6 August 2017

Genetic testing for dilated cardiomyopathy in clinical practice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4323670

8 July 2018

Evaluation of techniques for the quantification of myocardial scar of differing etiology using cardiac magnetic resonance

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4323670

8 July 2018

CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4323670

8 July 2018

Complementary prognostic values of stress myocardial perfusion and late gadolinium enhancement imaging by cardiac magnetic resonance in patients with known or suspected coronary artery disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4323670

8 July 2018

Temporal and mutation-specific alterations in Ca2+ homeostasis differentially determine the progression of cTnT-related cardiomyopathies in murine models

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4323670

8 July 2018

Proposal for contemporary screening strategies in families with hypertrophic cardiomyopathy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4323670

8 July 2018

Comparison of interstudy reproducibility of cardiovascular magnetic resonance with two-dimensional echocardiography in normal subjects and in patients with heart failure or left ventricular hypertrophy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4323670

8 July 2018

The L-type calcium channel inhibitor diltiazem prevents cardiomyopathy in a mouse model

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4323670

8 July 2018

Sarcomere protein gene mutations in hypertrophic cardiomyopathy of the elderly

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4323670

8 July 2018

The Genetic Basis for Cardiomyopathy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4323670

8 July 2018

An abnormal Ca(2+) response in mutant sarcomere protein-mediated familial hypertrophic cardiomyopathy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4323670

8 July 2018

Mutations in the gene for cardiac myosin-binding protein C and late-onset familial hypertrophic cardiomyopathy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4323670

8 July 2018

A familial hypertrophic cardiomyopathy locus maps to chromosome 15q2.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4323670

8 July 2018

A disease locus for familial hypertrophic cardiomyopathy maps to chromosome 1q3.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4323670

8 July 2018

Mutations in the genes for cardiac troponin T and alpha-tropomyosin in hypertrophic cardiomyopathy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4323670

8 July 2018

Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4323670

8 July 2018

A molecular basis for familial hypertrophic cardiomyopathy: a beta cardiac myosin heavy chain gene missense mutation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4323670

8 July 2018

Preclinical diagnosis of familial hypertrophic cardiomyopathy by genetic analysis of blood lymphocytes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4323670

8 July 2018

Characteristics and prognostic implications of myosin missense mutations in familial hypertrophic cardiomyopathy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4323670

8 July 2018

Diltiazem treatment prevents diastolic heart failure in mice with familial hypertrophic cardiomyopathy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4323670

27 September 2018

Theoretical and empirical derivation of cardiovascular allometric relationships in children.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4323670

27 September 2018

The genetic basis for cardiomyopathy: from mutation identification to mechanistic paradigms

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4323670

27 September 2018

Noninvasive assessment of left ventricular diastolic function by pulsed Doppler echocardiography in patients with hypertrophic cardiomyopathy

1 reference

https://pubmed.ncbi.nlm.nih.gov/25543971

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines

1 reference

https://pubmed.ncbi.nlm.nih.gov/25543971

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Two-dimensional echocardiographic calculation of left ventricular mass as recommended by the American Society of Echocardiography: correlation with autopsy and M-mode echocardiography

1 reference

https://pubmed.ncbi.nlm.nih.gov/25543971

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Validation of patient reports, automated pharmacy records, and pill counts with electronic monitoring of adherence to antihypertensive therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/25543971

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1016/J.JCHF.2014.08.003

1 reference

Europe PubMed Central

6 August 2017

1 reference

Europe PubMed Central

6 August 2017

1 reference

Europe PubMed Central

6 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35070184&oldid=1967052262"